Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Sleep Problems Common Among Patients With Psoriatic Arthritis
06/16/2023
Jolynn Tumolo
A new meta-analysis reveals that the prevalence of poor sleep quality among patients with psoriatic arthritis is 72.9%, significantly higher than in healthy controls.
A new meta-analysis reveals that the prevalence of poor sleep quality among patients with psoriatic arthritis is 72.9%, significantly higher than in healthy controls.
A new meta-analysis reveals that...
06/16/2023
First Report Managed Care
News
Motor Symptoms Worsen in Patients With Parkinson Disease, Post-COVID-19 Syndrome
06/16/2023
Jolynn Tumolo
A study showed that over 6 months, patients with Parkinson disease and post-COVID-19 syndrome experienced aggravated motor symptoms as well as new, unexpected nonmotor symptoms.
A study showed that over 6 months, patients with Parkinson disease and post-COVID-19 syndrome experienced aggravated motor symptoms as well as new, unexpected nonmotor symptoms.
A study showed that over 6...
06/16/2023
Annals of Long-Term Care
Hyperglycemia After Stroke Associated With Faster Cognitive Decline
News
Hyperglycemia After Stroke Associated With Faster Cognitive Decline
06/15/2023
Jolynn Tumolo
Higher blood glucose in stroke survivors was associated with faster decline in global cognition, according to a study published online in JAMA Network Open. 
Higher blood glucose in stroke survivors was associated with faster decline in global cognition, according to a study published online in JAMA Network Open. 
Higher blood glucose in stroke...
06/15/2023
Neurology
Cerebrospinal Fluid Biomarker May Inform ALS Diagnosis, Treatment
News
Cerebrospinal Fluid Biomarker May Inform ALS Diagnosis, Treatment
06/14/2023
Jolynn Tumolo
A newly discovered potential biomarker may aid in the diagnosis and treatment of sporadic amyotrophic lateral sclerosis (ALS), according to a research letter published in the Journal of Neurology, Neurosurgery, and Psychiatry. 
A newly discovered potential biomarker may aid in the diagnosis and treatment of sporadic amyotrophic lateral sclerosis (ALS), according to a research letter published in the Journal of Neurology, Neurosurgery, and Psychiatry. 
A newly discovered potential...
06/14/2023
Neurology
smoking
News
Varenicline Improves Smoking Abstinence in Individuals With MDD
06/13/2023
Jolynn Tumolo
In smokers with MDD, varenicline improved 27-week smoking cessation compared with placebo, according to recent study results.
In smokers with MDD, varenicline improved 27-week smoking cessation compared with placebo, according to recent study results.
In smokers with MDD, varenicline...
06/13/2023
Psych Congress Network
News
Tildrakizumab No Better Than Placebo for Ankylosing Spondylitis
06/09/2023
Jolynn Tumolo
A 48-week trial of tildrakizumab in patients with ankylosing spondylitis was terminated early after researchers found that the drug had no efficacy in comparison to placebo.
A 48-week trial of tildrakizumab in patients with ankylosing spondylitis was terminated early after researchers found that the drug had no efficacy in comparison to placebo.
A 48-week trial of tildrakizumab...
06/09/2023
First Report Managed Care
News
Therapy Improves Type 2 Asthma Outcomes Regardless of Allergic Status
06/09/2023
Jolynn Tumolo
Researchers found that long-term treatment with dupilumab improved outcomes in patients with moderate-to-severe GINA-based type 2 asthma, regardless of allergic status.
Researchers found that long-term treatment with dupilumab improved outcomes in patients with moderate-to-severe GINA-based type 2 asthma, regardless of allergic status.
Researchers found that long-term...
06/09/2023
First Report Managed Care
News
After Declaring Bankruptcy, Akorn Pulls More Than 50 Medications
06/09/2023
Jolynn Tumolo
More than 50 medications have been issued recalls after a nationwide distributor declared bankruptcy and discontinued their quality program.
More than 50 medications have been issued recalls after a nationwide distributor declared bankruptcy and discontinued their quality program.
More than 50 medications have...
06/09/2023
Pharmacy Learning Network
News
Class I Recall for Children’s OTC Cold Medicine
06/09/2023
Jolynn Tumolo
A Class I recall has been issued for over-the-counter pediatric cough medicine due to a product mix-up.
A Class I recall has been issued for over-the-counter pediatric cough medicine due to a product mix-up.
A Class I recall has been issued...
06/09/2023
Pharmacy Learning Network
News
Interleukin-17 Inhibitors May Improve Psoriasis Symptoms When TNF Inhibitors Do Not
06/08/2023
Jolynn Tumolo
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17...
06/08/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use